Racial/Ethnic Disparities in Environmental Endocrine Disrupting Chemicals and Women’s Reproductive Health Outcomes: Epidemiological Examples Across the Life Course
- 521 Downloads
Disparities in women’s reproductive health outcomes across the life course have been well-documented. Endocrine disrupting chemicals may be one factor driving disparities, as studies suggest exposure to certain environmental endocrine disrupting chemicals, such as certain phthalates, bisphenol A, parabens, and polybrominated diphenyl ethers, is higher in non-Whites. Yet, a limited amount of research has focused on these chemical exposures as a potential mediator of racial/ethnic differences in women’s reproductive health outcomes, such as pubertal development, fibroids, infertility, and pregnancy complications. Given that race/ethnicity is a social construct, the purpose of this review was to present the current state of the literature on racial/ethnic disparities in both environmental endocrine disrupting chemicals, as well as associations between these chemicals and selected women’s reproductive health outcomes. Our goal was to evaluate literature from populations based in the USA to (1) characterize racial/ethnic differences in environmental endocrine disrupting chemicals and (2) systematically review literature on environmental endocrine disrupting chemicals and selected women’s health outcomes in populations containing more than one racial/ethnic group. This review highlights the need for future work in determining whether higher exposures to some environmental endocrine disrupting chemicals might partly explain differences in women’s reproductive health outcomes in these higher-exposure and high-risk groups.
KeywordsRace Ethnicity Endocrine disruptors Women’s health
We would like to thank Carol Mita, the Reference & Education Services Librarian at Harvard Medical School’s Countway Library of Medicine.
Sources of Financial Support
T.J-T. was supported by the National Institute of Environmental Health Sciences (R01ES026166). A.Z. was supported by the National Institute of Environmental Health Sciences (R00ES019881). Y.-H.C. was supported by the Irene M. and Fredrick J. Stare Nutrition Education Fund.
Compliance with Ethical Standards
Conflict of Interest
Tamarra M. James-Todd, Yu-Han Chiu, and Ami R. Zota declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 12.Branch F, Woodruff TJ, Mitro SD, Zota AR. Vaginal douching and racial/ethnic disparities in phthalates exposures among reproductive-aged women: National Health and Nutrition Examination Survey 2001–2004. Environ Health Global Access Scie Source. 2015;14:57. doi: 10.1186/s12940-015-0043-6.Google Scholar
- 16.Ye X, Wong LY, Zhou X, Calafat AM. Urinary concentrations of 2,4-dichlorophenol and 2,5-dichlorophenol in the U.S. population (National Health and Nutrition Examination Survey, 2003–2010): trends and predictors. Environ Health Perspect. 2014;122(4):351–5. doi: 10.1289/ehp.1306816.PubMedPubMedCentralGoogle Scholar
- 20.National Institute of Environmental Health Sciences. 2012–2017 Strategic Plan: advancing science, improving health: a plan for environmental health research. U.S. Department of Health and Human Services, National Institutes of Health. NIH No. 12–7935. http://www.niehs.nih.gov/about/strategicplan/strategicplan2012_508.pdf. Accessed February 4, 2016 2016.
- 21.US EPA (Environmental Protection Agency). Phthalates Action Plan (Revised) 2012.Google Scholar
- 33.•Werner EF, Braun JM, Yolton K, Khoury JC, Lanphear BP. The association between maternal urinary phthalate concentrations and blood pressure in pregnancy: the HOME Study. Environl Health Global Access Scie Source. 2015;14:75. doi: 10.1186/s12940-015-0062-3. This study is among the first to publish on urinary phthalate metabolites and blood pressure in pregnancy, with implications for pregnancy-induced hypertension. With a large proportion of the population being non-White, this study provides an opportunity to further explore racial/ethnic differences in EDC exposures and their contribution to disparities in blood pressure-related outcomes in pregnancy. Google Scholar
- 35.Meeker JD, Cantonwine DE, Rivera-Gonzalez LO, Ferguson KK, Mukherjee B, Calafat AM, et al. Distribution, variability, and predictors of urinary concentrations of phenols and parabens among pregnant women in Puerto Rico. Environ Sci Technol. 2013;47(7):3439–47. doi: 10.1021/es400510g.PubMedPubMedCentralGoogle Scholar
- 39.Philippat C, Wolff MS, Calafat AM, Ye X, Bausell R, Meadows M, et al. Prenatal exposure to environmental phenols: concentrations in amniotic fluid and variability in urinary concentrations during pregnancy. Environ Health Perspect. 2013;121(10):1225–31. doi: 10.1289/ehp.1206335.PubMedPubMedCentralGoogle Scholar
- 44.Veiga-Lopez A, Kannan K, Liao C, Ye W, Domino SE, Padmanabhan V. Gender-specific effects on gestational length and birth weight by early pregnancy BPA exposure. J Clin Endocrinol Metab. 2015; 100(11):E1394-E403.Google Scholar
- 50.Zota AR, Linderholm L, Park JS, Petreas M, Guo T, Privalsky ML, et al. Temporal comparison of PBDEs, OH-PBDEs, PCBs, and OH-PCBs in the serum of second trimester pregnant women recruited from San Francisco General Hospital, California. Environ Sci Technol. 2013;47(20):11776–84. doi: 10.1021/es402204y.PubMedPubMedCentralCrossRefGoogle Scholar
- 52.Windham GC, Pinney SM, Sjodin A, Lum R, Jones RS, Needham LL, et al. Body burdens of brominated flame retardants and other persistent organo-halogenated compounds and their descriptors in US girls. Environ Res. 2010;110(3):251–7. doi: 10.1016/j.envres.2010.01.004.PubMedPubMedCentralCrossRefGoogle Scholar
- 53.Vuong AM, Webster GM, Romano ME, Braun JM, Zoeller RT, Hoofnagle AN, et al. Maternal polybrominated diphenyl ether (PBDE) exposure and thyroid hormones in maternal and cord sera: the HOME Study, Cincinnati. USA Environ Health Perspect. 2015;123(10):1079–85. doi: 10.1289/ehp.1408996.PubMedGoogle Scholar
- 58.Phthalates and cumulative risk assessment: the tasks ahead. Washington (DC) 2008.Google Scholar
- 61.Howdeshell KL, Wilson VS, Furr J, Lambright CR, Rider CV, Blystone CR, et al. A mixture of five phthalate esters inhibits fetal testicular testosterone production in the Sprague–Dawley rat in a cumulative, dose-additive manner. Toxicol Sci. 2008;105(1):153–65. doi: 10.1093/toxsci/kfn077.PubMedCrossRefGoogle Scholar
- 73.•Windham GC, Pinney SM, Voss RW, Sjodin A, Biro FM, Greenspan LC, et al. Brominated flame retardants and other persistent organohalogenated compounds in relation to timing of puberty in a longitudinal study of girls. Environ Health Perspect. 2015;123(10):1046–52. doi: 10.1289/ehp.1408778. This prospective study was important to our review, as it was conducted in a large, multi-racial/ethnic study population, noting racial/ethnic differences in exposure patterns. This diverse study population coupled with assessment of exposures and outcomes that are racially/ethnically patterned enable further assessment of racial/ethnic disparities in this area of research. PubMedPubMedCentralGoogle Scholar
- 75.•Wolff MS, Teitelbaum SL, McGovern K, Pinney SM, Windham GC, Galvez M, et al. Environmental phenols and pubertal development in girls. Environ Int. 2015;84:174–80. doi: 10.1016/j.envint.2015.08.008. This prospective study was designed to have a racially/ethnically diverse study population that allows for assessment of multiple pubertal outcomes. As one of the more recent studies published from this cohort, it provides important information about racial/ethnic differences in the exposure and outcome, which is critical for future analyses evaluating EDCs’ contribution to racial/ethnic disparities in these outcomes. PubMedCrossRefGoogle Scholar
- 80.Thoma ME, McLain AC, Louis JF, King RB, Trumble AC, Sundaram R, et al. Prevalence of infertility in the United States as estimated by the current duration approach and a traditional constructed approach. Fertil Steril. 2013;99(5):1324–31 e1. doi: 10.1016/j.fertnstert.2012.11.037.PubMedPubMedCentralCrossRefGoogle Scholar
- 81.Chandra A, Copen CE, Stephen EH. Infertility and impaired fecundity in the United States, 1982–2010: data from the National Survey of Family Growth. Natl Health Stat Rep. 2013;(67):1–18, 1 p following 9.Google Scholar
- 83.McCarthy-Keith DM, Schisterman EF, Robinson RD, O’Leary K, Lucidi RS, Armstrong AY. Will decreasing assisted reproduction technology costs improve utilization and outcomes among minority women? Fertil Steril. 2010;94(7):2587–9. doi: 10.1016/j.fertnstert.2010.02.021.PubMedPubMedCentralCrossRefGoogle Scholar
- 89.Souter I, Smith KW, Dimitriadis I, Ehrlich S, Williams PL, Calafat AM, et al. The association of bisphenol-A urinary concentrations with antral follicle counts and other measures of ovarian reserve in women undergoing infertility treatments. Reprod Toxicol (Elmsford NY). 2013;42:224–31. doi: 10.1016/j.reprotox.2013.09.008.CrossRefGoogle Scholar
- 91.Messerlian C, Souter I, Gaskins AJ, Williams PL, Ford JB, Chiu YH, et al. Urinary phthalate metabolites and ovarian reserve among women seeking infertility care. Hum Reprod (Oxfor Engl). 2015. 10.1093/humrep/dev292.Google Scholar
- 93.Buck Louis GM, Sundaram R, Sweeney AM, Schisterman EF, Maisog J, Kannan K. Urinary bisphenol A, phthalates, and couple fecundity: the Longitudinal Investigation of Fertility and the Environment (LIFE) study. Fertil Steril. 2014;101(5):1359–66. doi: 10.1016/j.fertnstert.2014.01.022.PubMedCrossRefGoogle Scholar
- 96.Minguez-Alarcon L, Gaskins AJ, Chiu YH, Williams PL, Ehrlich S, Chavarro JE, et al. Urinary bisphenol A concentrations and association with in vitro fertilization outcomes among women from a fertility clinic. Hum Reprod (Oxford Engl). 2015;30(9):2120–8. doi: 10.1093/humrep/dev183.CrossRefGoogle Scholar
- 98.Alur S, Wang H, Hoeger K, Swan SH, Sathyanarayana S, Redmon BJ, et al. Urinary phthalate metabolite concentrations in relation to history of infertility and use of assisted reproductive technology. Fertil Steril. 2015;104(5):1227–35. doi: 10.1016/j.fertnstert.2015.07.1150.PubMedCrossRefGoogle Scholar
- 99.Jukic AM, Calafat AM, McConnaughey DR, Longnecker MP, Hoppin JA, Weinberg CR, et al. Urinary concentrations of phthalate metabolites and bisphenol A and associations with follicular-phase length, luteal-phase length, fecundability, and early pregnancy loss. Environ Health Perspect. 2015. doi: 10.1289/ehp.1408164.PubMedPubMedCentralGoogle Scholar
- 104.•Ferguson KK, McElrath TF, Meeker JD. Environmental phthalate exposure and preterm birth. JAMA Pediatr. 2014;168(1):61–7. doi: 10.1001/jamapediatrics.2013.3699. Several studies have been published from this racially/ethnically diverse study population, evaluating an important pregnancy outcome that is racially/ethnically disparate—preterm birth. The study found certain phthalate metabolites to be associated with a higher risk of preterm birth, which could be further explored to determine whether exposure to certain phthalates contributes to racial/ethnic differences in this outcome. PubMedPubMedCentralCrossRefGoogle Scholar
- 114.Committee on Women’s Health Research, Institute of Medicine of the National Academies. Women’s health research: progress, pitfalls, and promise. Report Brief. 2010.Google Scholar